Sugamura K - Search Results

1

Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.

Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM. Weil-Hillman G, et al. Among authors: sugamura k. Cancer Res. 1990 May 1;50(9):2683-91. Cancer Res. 1990. PMID: 1691679

2

Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding.

Voss SD, Robb RJ, Weil-Hillman G, Hank JA, Sugamura K, Tsudo M, Sondel PM. Voss SD, et al. Among authors: sugamura k. J Exp Med. 1990 Oct 1;172(4):1101-14. doi: 10.1084/jem.172.4.1101. J Exp Med. 1990. PMID: 1698909 Free PMC article.

3

Macrophage-T cell interaction is essential for the induction of p75 interleukin 2 (IL-2) receptor and IL-2 responsiveness in human CD4+ T cells.

Nakamura Y, Nishimura T, Tokuda Y, Kobayashi N, Watanabe K, Noto T, Mitomi T, Sugamura K, Habu S. Nakamura Y, et al. Among authors: sugamura k. Jpn J Cancer Res. 1991 Mar;82(3):257-61. doi: 10.1111/j.1349-7006.1991.tb01839.x. Jpn J Cancer Res. 1991. PMID: 1902447 Free PMC article.

4

Activation of natural killer cells via the p75 interleukin 2 receptor.

Phillips JH, Takeshita T, Sugamura K, Lanier LL. Phillips JH, et al. Among authors: sugamura k. J Exp Med. 1989 Jul 1;170(1):291-6. doi: 10.1084/jem.170.1.291. J Exp Med. 1989. PMID: 2787381 Free PMC article.

5

Differential expression of the interleukin 2 receptor beta (p75) chain on human peripheral blood natural killer subsets.

Nishikawa K, Saito S, Morii T, Kato Y, Narita N, Ichijo M, Ohashi Y, Takeshita T, Sugamura K. Nishikawa K, et al. Among authors: sugamura k. Int Immunol. 1990;2(6):481-6. doi: 10.1093/intimm/2.6.481. Int Immunol. 1990. PMID: 1707657

6

Activation of peripheral blood T cells via the p75 interleukin 2 receptor.

Yagita H, Nakata M, Azuma A, Nitta T, Takeshita T, Sugamura K, Okumura K. Yagita H, et al. Among authors: sugamura k. J Exp Med. 1989 Oct 1;170(4):1445-50. doi: 10.1084/jem.170.4.1445. J Exp Med. 1989. PMID: 2571670 Free PMC article.

7

Adenovirus vector-mediated in vivo gene transfer of OX40 ligand to tumor cells enhances antitumor immunity of tumor-bearing hosts.

Andarini S, Kikuchi T, Nukiwa M, Pradono P, Suzuki T, Ohkouchi S, Inoue A, Maemondo M, Ishii N, Saijo Y, Sugamura K, Nukiwa T. Andarini S, et al. Among authors: sugamura k. Cancer Res. 2004 May 1;64(9):3281-7. doi: 10.1158/0008-5472.can-03-3911. Cancer Res. 2004. PMID: 15126371

8

Expression and role of p75 interleukin 2 receptor on human monocytes.

Espinoza-Delgado I, Ortaldo JR, Winkler-Pickett R, Sugamura K, Varesio L, Longo DL. Espinoza-Delgado I, et al. Among authors: sugamura k. J Exp Med. 1990 May 1;171(5):1821-6. doi: 10.1084/jem.171.5.1821. J Exp Med. 1990. PMID: 2110244 Free PMC article.

9

Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.

Takeshita T, Goto Y, Tada K, Nagata K, Asao H, Sugamura K. Takeshita T, et al. Among authors: sugamura k. J Exp Med. 1989 Apr 1;169(4):1323-32. doi: 10.1084/jem.169.4.1323. J Exp Med. 1989. PMID: 2784485 Free PMC article.

10

Accumulation of CD16-CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua.

Nishikawa K, Saito S, Morii T, Hamada K, Ako H, Narita N, Ichijo M, Kurahayashi M, Sugamura K. Nishikawa K, et al. Among authors: sugamura k. Int Immunol. 1991 Aug;3(8):743-50. doi: 10.1093/intimm/3.8.743. Int Immunol. 1991. PMID: 1716974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters